Richard Chesworth - Aug 17, 2021 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Scientific Officer
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Stock symbol: KYMR
Transactions as of: Aug 17, 2021
Transactions value $: -$1,640,182
Form type: 4
Date filed: 8/19/2021, 04:30 PM
Next filing: Aug 27, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$1.08M	+54K		$20.00	54K	Aug 17, 2021	Direct
transaction	KYMR	Common Stock	Sale	-$440K	-8.81K	-16.31%	$49.90	45.2K	Aug 17, 2021	Direct	F1, F2
transaction	KYMR	Common Stock	Sale	-$2.11M	-42K	-92.88%	$50.37	3.22K	Aug 17, 2021	Direct	F1, F3
transaction	KYMR	Common Stock	Sale	-$151K	-2.93K	-91.04%	$51.68	288	Aug 17, 2021	Direct	F1, F4
transaction	KYMR	Common Stock	Sale	-$15K	-288	-100%	$52.09	0	Aug 17, 2021	Direct	F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-54K	-15.38%	$0.00	297K	Aug 17, 2021	Common Stock	54K	$20.00	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.04 to $50.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.04 to $51.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.05 to $52.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.06 to $52.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6	Twenty-five percent (25%) of the shares subject to this option vested and became exercisable on August 17, 2021, and the remainder of the shares shall vest in equal monthly installments for a period of thirty-six (36) months thereafter.